MedTrace Logo

Topical Anesthetic for Procedures Through the Nose

NCT02667054 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 648

Last updated 2016-05-17

No results posted yet for this study

Summary

To determine if RX0041-002 is a safe and effective topical anesthetic.

Conditions

  • Drug Reaction to Analgesic Nos

Interventions

DRUG

RX0041 4%

Anesthetic

DRUG

Placebo

Placebo Comparator

DRUG

RX0041 8%

Anesthetic

Sponsors & Collaborators

  • Pharmaceutical Project Solutions, Inc.

    lead INDUSTRY

Principal Investigators

  • Melissa L Goodhead, MSc · PPSI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667054 on ClinicalTrials.gov